retatrutide fat loss clinical trial results Weight Treatment Explained A New Obesity Drug Delivered

Beyond the results, the support made a huge difference

Semaglutide does this too, but the glucagon component in retatrutide may amplify this effect

From our data, it seems clear that retatrutide can act in cardiomyocytes in the HAP

The most commonly reported side effects were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and occurred mainly during dose escalation

2 Harvard Medical School, Boston, Massachusetts, USA

In one trial, about 66 per cent of people on trizepatide lost more than 10 per cent of their body weight in one year, compared to 41 per cent on semaglutide